Terumo Corp 4543
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥2,429.50
- Day Range
- ¥2,399.00–2,506.00
- 52-Week Range
- ¥1,900.00–2,689.00
- Bid/Ask
- ¥2,398.00 / ¥2,402.50
- Shares Outstanding
- 1.48B
- Market Cap
- ¥3.54T
- Volume/Avg
- 8M / 5M
Key Statistics
- Price/Earnings (Normalized)
- 19.90
- Price/Sales
- 2.99
- Dividend Yield (Trailing)
- 1.38%
- Dividend Yield (Forward)
- 1.50%
- Dividend Payment Schedule
- Jun, Dec
- Total Yield
- 1.38%
Company Profile
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo’s revenue.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Large Core
- Total Number of Employees
- 31,185
- Website
- https://www.terumo.co.jp
Valuation
|
Metric
|
4543
|
|---|---|
Price/Earnings (Normalized) | 19.90 |
Price/Book Value | 2.13 |
Price/Sales | 2.99 |
Price/Cash Flow | 12.00 |
Price/Earnings
4543
Financial Strength
|
Metric
|
4543
|
|---|---|
Quick Ratio | 1.31 |
Current Ratio | 2.19 |
Interest Coverage | 60.00 |
Quick Ratio
4543
Profitability
|
Metric
|
4543
|
|---|---|
Return on Assets (Normalized) | 8.18% |
Return on Equity (Normalized) | 11.49% |
Return on Invested Capital (Normalized) | 9.41% |
Return on Assets
4543
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| LOCK|?YJ%m#q | LOCK|K&ZBY | $179B | |||
| Medtronic PLC
MDT
| LOCK|KfRJkV | LOCK|D<pf | $122B | |||
| Stryker Corp
SYK
| LOCK|Z^z^<j## | LOCK|d&c | $118B | |||
| Boston Scientific Corp
BSX
| LOCK|H&r#wP | LOCK|!BVHt | $66B | |||
| Edwards Lifesciences Corp
EW
| LOCK|<sq<%&&% | LOCK|$#gxV | $51B | |||
| GE HealthCare Technologies Inc Common Stock
GEHC
| LOCK|&!x&%^! | LOCK|?r | $32B | |||
| DexCom Inc
DXCM
| LOCK|xFtK$p^ | LOCK|NMs@y | $29B | |||
| Koninklijke Philips NV ADR
PHG
| LOCK|C<$ | LOCK|<nm | $26B | |||
| Steris PLC
STE
| LOCK|qM#c?n | LOCK|VJn&^ | $23B | |||
| Zimmer Biomet Holdings Inc
ZBH
| LOCK|>F@&@&Wv | LOCK|#$ | $19B |
United States